Table 3.

Serum MMP-2 and MMP-9 levels in brain metastasis patients

Case	Sex	Age	Diagnosis	Localization	Serum MMPs (vol × 10−3)
					MMP-9 (240 kDa)	MMP-9 (130 kDa)	MMP-9 (92 kDa)	MMP-2 (72 kDa)
49	M	64	Melanoma	Left temporal lobe	212	nd	1233	755
50	M	61	Melanoma	Right frontal lobe	160	67	1426	703
51	M	66	Melanoma	Cerebellum	208	104	1717	330
52	M	50	Melanoma	Frontal lobe	100	45	940	384
53	F	58	Melanoma	Encephalon, NOS	198	318	1183	540
54	F	52	Melanoma	Left frontal lobe	145	111	1450	1228
55	M	32	Melanoma	Parietal lobe	149	233	1194	334
56	M	77	Melanoma	Encephalon, NOS	306	719	2040	1132
57	M	67	Melanoma	Right temporal lobe	305	217	1531	470
58	M	80	Melanoma	Right occipital lobe	89	nd	556	353
59	F	87	NSCLC	Right cerebellum	254	nd	1202	518
60	M	57	NSCLC	Left occipital lobe	361	195	1672	485
61	M	48	NSCLC	Encephalon, NOS	185	72	1473	781
62	M	72	NSCLC	Left frontal lobe	140	nd	1277	535
63	M	55	NSCLC	Left cerebellum	403	235	1740	1012
64	M	71	SCLC	Cerebellum	122	147	1217	237
65	F	67	Breast Ca	--	80	nd	1097	634
66	F	77	Colon Ca	Cerebellum	121	51	1066	334
67	M	73	Kidney Ca	Left frontal lobe	117	103	1077	213
68	F	77	Urogenital Ca	Left frontal lobe	135	164	1143	125

NSCLC non-small lung carcinoma, SCLC small lung carcinoma, MMP matrix-metalloproteinase, nd not detectable